GSK, Novartis And Teva COPD Drugs Breeze Through EMA Together
This article was originally published in The Pink Sheet Daily
Executive Summary
The EMA has recommended for authorization drugs from GSK, Novartis and Teva, setting the scene for a show-down in the increasingly competitive European COPD respiratory market.